CDKN2A and cancer: It expresses mucin and high levels of angiogenic factors and cancer stem cell markers [16,20] and lacks KRAS mutations but harbors mutations in TP53 and homozygous deletions in CDKN2A/p16 and SMAD4/DPC4 [16].